Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 10 Mar 2023
Bhopal: Bhopal Memorial Hospital & Research Center (BMHRC) will close two main offices.
Read Full NewsCuda discussed the potential of the NIH toolbox to easily assess cognitive effects in clinical trials.
Friedberg discusses the inconsistent clinical pathways from disease progression to intervention in patients with a pair of highly deadly lung diseases.
New findings from the LUMINA trial reveal AMX0114's safety in ALS patients, paving the way for further research and potential treatment advancements.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on neuromodulation for Parkinson disease!
Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors
Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia
Teva Pharmaceuticals Submits NDA on TEV-‘749 for Schizophrenia to the FDA
1.
Since 2000, the outlook for multiple myeloma has improved.
2.
Ineffective medication can remove the "worst fear" of schizophrenia.
3.
BMTs that are "half-matched" are effective in treating severe sickle cell disease.
4.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
5.
According to a study, white Americans are overdiagnosing melanoma at an alarming rate.
1.
Gene Signatures and Their Implications in Oncology: Decoding the Blueprint for Personalized Cancer Treatment
2.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
3.
Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy
4.
Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment
5.
Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
3.
Efficient Management of First line ALK-rearranged NSCLC - Part V
4.
Updates on Standard V/S High Risk Myeloma Treatment
5.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge